Matches in SemOpenAlex for { <https://semopenalex.org/work/W2414894904> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W2414894904 endingPage "71" @default.
- W2414894904 startingPage "766" @default.
- W2414894904 abstract "To evaluate the effects of cyclosporine A (CsA) whole-blood concentration on the early response to immunosuppressive therapy (IST) in severe and very severe aplastic anemia (SAA/VSAA).Ninety SAA/VSAA patients treated with rabbit antithymocyte globulin (ATG) plus CsA as first line therapy in our hospital were retrospectively analysed. CsA levels between the response group and non-response group, and response rates of patients with variant CsA levels were compared respectively.(1) There was no significant difference in the beginning unmodified CsA blood concentration between IST responded and non-responded SAA/VSAA patients. The beginning unmodified C(0) 133.91 ug/L in IST 2-month responders was higher than that of 49.9 ug/L in non-responded SAA patients (P = 0.009); (2) The mean CsA C(0) and C(2) levels during the third month following IST were significantly different in responders and non-responders(197.52 µg/L vs 161.49 µg/L, P = 0.024, and 738.76 µg/L vs 615.46 µg/L, P = 0.009), and no significant difference in other periods of IST (P > 0.05); (3) The response rate (87.5%) was significantly higher in patients with CsA C(0) ≥ 200µg/L the third month following IST than those of 55.6% in patients with CsA C(0) 150 - 200 µg/L (P = 0.023) and 59.3% in patients with CsA C(0) < 150 µg/L (P = 0.046), respectively. The response rate was significantly higher of C(2) ≥ 700 µg/L group than that of C(2) < 700 µg/L group (80.5%vs 55.3%, P = 0.012).The CsA concentration related to the early IST response. The third month CsA concentrations was the most important for the response and maintaining CsA levels with C(0) ≥ 200 µg/L and C(2) ≥ 700 µg/L may improve the response to IST in SAA/VSAA." @default.
- W2414894904 created "2016-06-24" @default.
- W2414894904 creator A5021391037 @default.
- W2414894904 creator A5022067448 @default.
- W2414894904 creator A5027812420 @default.
- W2414894904 creator A5030252931 @default.
- W2414894904 creator A5034184396 @default.
- W2414894904 creator A5043888244 @default.
- W2414894904 creator A5046262151 @default.
- W2414894904 creator A5050704516 @default.
- W2414894904 creator A5062179186 @default.
- W2414894904 creator A5065341712 @default.
- W2414894904 creator A5066155109 @default.
- W2414894904 creator A5087232395 @default.
- W2414894904 creator A5091136705 @default.
- W2414894904 creator A5091484159 @default.
- W2414894904 date "2011-11-01" @default.
- W2414894904 modified "2023-09-23" @default.
- W2414894904 title "[Effects of concentration of cyclosporine A on the early response to immunosuppressive therapy in severe aplastic anemia]." @default.
- W2414894904 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22339914" @default.
- W2414894904 hasPublicationYear "2011" @default.
- W2414894904 type Work @default.
- W2414894904 sameAs 2414894904 @default.
- W2414894904 citedByCount "0" @default.
- W2414894904 crossrefType "journal-article" @default.
- W2414894904 hasAuthorship W2414894904A5021391037 @default.
- W2414894904 hasAuthorship W2414894904A5022067448 @default.
- W2414894904 hasAuthorship W2414894904A5027812420 @default.
- W2414894904 hasAuthorship W2414894904A5030252931 @default.
- W2414894904 hasAuthorship W2414894904A5034184396 @default.
- W2414894904 hasAuthorship W2414894904A5043888244 @default.
- W2414894904 hasAuthorship W2414894904A5046262151 @default.
- W2414894904 hasAuthorship W2414894904A5050704516 @default.
- W2414894904 hasAuthorship W2414894904A5062179186 @default.
- W2414894904 hasAuthorship W2414894904A5065341712 @default.
- W2414894904 hasAuthorship W2414894904A5066155109 @default.
- W2414894904 hasAuthorship W2414894904A5087232395 @default.
- W2414894904 hasAuthorship W2414894904A5091136705 @default.
- W2414894904 hasAuthorship W2414894904A5091484159 @default.
- W2414894904 hasConcept C126322002 @default.
- W2414894904 hasConcept C2776694085 @default.
- W2414894904 hasConcept C2778248108 @default.
- W2414894904 hasConcept C2780007613 @default.
- W2414894904 hasConcept C2781440808 @default.
- W2414894904 hasConcept C3019096185 @default.
- W2414894904 hasConcept C71924100 @default.
- W2414894904 hasConcept C81358767 @default.
- W2414894904 hasConcept C90924648 @default.
- W2414894904 hasConceptScore W2414894904C126322002 @default.
- W2414894904 hasConceptScore W2414894904C2776694085 @default.
- W2414894904 hasConceptScore W2414894904C2778248108 @default.
- W2414894904 hasConceptScore W2414894904C2780007613 @default.
- W2414894904 hasConceptScore W2414894904C2781440808 @default.
- W2414894904 hasConceptScore W2414894904C3019096185 @default.
- W2414894904 hasConceptScore W2414894904C71924100 @default.
- W2414894904 hasConceptScore W2414894904C81358767 @default.
- W2414894904 hasConceptScore W2414894904C90924648 @default.
- W2414894904 hasIssue "11" @default.
- W2414894904 hasLocation W24148949041 @default.
- W2414894904 hasOpenAccess W2414894904 @default.
- W2414894904 hasPrimaryLocation W24148949041 @default.
- W2414894904 hasRelatedWork W2031440249 @default.
- W2414894904 hasRelatedWork W2342188895 @default.
- W2414894904 hasRelatedWork W2351079850 @default.
- W2414894904 hasRelatedWork W2369463385 @default.
- W2414894904 hasRelatedWork W2369946283 @default.
- W2414894904 hasRelatedWork W2391113732 @default.
- W2414894904 hasRelatedWork W2414086058 @default.
- W2414894904 hasRelatedWork W2415665637 @default.
- W2414894904 hasRelatedWork W2416324407 @default.
- W2414894904 hasRelatedWork W2417810342 @default.
- W2414894904 hasVolume "32" @default.
- W2414894904 isParatext "false" @default.
- W2414894904 isRetracted "false" @default.
- W2414894904 magId "2414894904" @default.
- W2414894904 workType "article" @default.